Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is a highly prevalent disease with no specific drug therapy. High-throughput metabolomics present an unprecedented opportunity to identify biomarkers and potentially causal risk factors for NAFLD. Here, we determined the impact of 21 circulating metabolites,...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagnon, Eloi, Manikpurage, Hasanga D., Mitchell, Patricia L., Girard, Arnaud, Gobeil, Émilie, Bourgault, Jérôme, Bégin, Frédéric, Marette, André, Thériault, Sébastien, Arsenault, Benoit J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339047/
https://www.ncbi.nlm.nih.gov/pubmed/37456853
http://dx.doi.org/10.1016/j.isci.2023.107127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339047/
https://www.ncbi.nlm.nih.gov/pubmed/37456853
http://dx.doi.org/10.1016/j.isci.2023.107127

Ejemplares similares